Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells attack tumor and infected cells, but the receptors and ligands that stimulate them are poorly understood. Here we report the expression cloning of two murine ligands for the lectin-like receptor NKG2D. The two ligands, H-60 and Rae1 beta, are distant relatives of major histocompatibility complex class I molecules. NKG2D ligands are not expressed by most normal cells but are up-regulated on numerous tumor cells. We show that mouse NKG2D is expressed by NK cells, activated CD8+ T cells and activated macrophages. Expression of either NKG2D ligand by target cells triggers NK cell cytotoxicity and interferon-gamma secretion by NK cells, as well as nitric oxide release and tumor necrosis factor alpha transcription by macrophages. Thus, through their interaction with NKG2D, H-60 and Rae1 beta are newly identified potent stimulators of innate immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies from our laboratory demonstrated that transplanted tumor cells expressing NKG2D ligands are rejected by NK cells and, in some cases, T cells (Diefenbach et al., 2000, 2001, 2003)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Diefenbach et al., 2000
Citations
Cites
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146 · cited 1×
“The extrachromosomal DNA was extracted from the sorted cells as describe”
MethodPhenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“The recombinant protein was purified from inclusion bodies and refolded in vitro as describe”
MethodActivation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999 · cited 1×
“The MHC-encoded proteins MICA and the closely related MICB are distantly related to MHC class I protein”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · cited 2×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodIn search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialProduction of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialAn Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039 · cited 1×
“Recent evidence indicates that human NKG2D forms a homodimer that associates with the signaling subunit DAP10 on the surface of NK cells and CD8 + T cell”
BackgroundBroad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017 · cited 1×
“MICA and MICB are normally expressed on a subset of intestinal epithelial cells, but their expression is up-regulated by cellular stres”
Background
Research works printed but not linked: 2
- Cosman, D. et al. The human cytomegalovirus (HCMV) glycoprotein, UL16, binds to the MHC class I-related protein, MICB/PERB11, and to two novel, MHC class I-related molecules, ULBP1 and ULBP2. FASEB J. 14, A1018 (2000).
- Chalupny, J. et al. Soluble forms of the novel MHC class I–related molecules, ULBP1 and ULBP2, bind to, and functionally activate NK cells. FASEB J. 14, A1018 (2000).
Cited by
Items 301–400 of 875
The functional impairment of natural killer cells during influenza virus infection
Guo, H., Kumar, P., Moran, T. M., García‐Sastre, A., Zhou, Y., & Malarkannan, S. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.60 · Cited by 71
Sun, X., Glynn, D. J., Hodson, L. J., Huo, C. W., Britt, K. L., Thompson, E. W., Woolford, L., Evdokiou, A., Pollard, J. W., Robertson, S. A., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-016-0796-z · Cited by 82
Evasion of myofibroblasts from immune surveillance: A mechanism for tissue fibrosis
Wallach‐Dayan, S. B., Golan‐Gerstl, R., & Breuer, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705582104 · Cited by 75
y Fortéa, J. O., Giraud, É., Regnault, B., Coppée, J., Milon, G., Lang, T., & Prina, E. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-119 · Cited by 79
“Interestingly, NKG2D receptor engagement by H60 ligand in MΦ, that normally leads to the production of MΦ leishmanicidal molecules such as NO and TNF-α [20], could be impaired in MΦ hosting amastigotes since the expression of klrk1 gene was also downmodulated (-1.”
BackgroundInfluentialRoutes, J. M., Ryan, S., Morris, K. R., Takaki, R., Cerwenka, A., & Lanier, L. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050240 · Cited by 82
“The ectopic expression of NKG2D ligands on tumors has been shown to target these cells to lysis in vivo by both NK cells and T cells (9, 10, 22).”
BackgroundImpaired natural killer cell self-education and “missing-self” responses in Ly49-deficient mice
Bélanger, S., Tu, M. M., Rahim, M. M. A., Mahmoud, A. B., Patel, R., Tai, L., Troke, A. D., Wilhelm, B. T., Landry, J., Zhu, Q., et al. (2012) · Blood · doi:10.1182/blood-2012-02-408732 · Cited by 69
Self-citationSpecific recognition of virus‐infected cells by paired NK receptors
Arase, H., & Lanier, L. L. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.422 · Cited by 79
“NKG2D recognises MIC [34] and ULBP ligands [35] in human and RAE-1, H60 [36,37] and MULT-1 ligands [38] in mice.”
BackgroundMasle‐Farquhar, E., Jackson, K., Peters, T. J., Al‐Eryani, G., Singh, M., Payne, K. J., Rao, G., Avery, D. T., Apps, G., Kingham, J., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.11.001 · Cited by 71
Mizutani, T., Neugebauer, N., Putz, E. M., Moritz, N., Simma, O., Zebedin-Brandl, E., Gotthardt, D., Warsch, W., Eckelhart, E., Kantner, H.-P., et al. (2012) · OncoImmunology · doi:10.4161/onci.21284 · Cited by 68
Recognition of tumor cells by the innate immune system
Soloski, M. J. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00198-9 · Cited by 78
Studies of ex Vivo Activated and Expanded CD8+ NK-T Cells in Humans and Mice
Verneris, M. R., Baker, J. B., Edinger, M., & Negrin, R. S. (2002) · Journal of Clinical Immunology · doi:10.1023/a:1015415928521 · Cited by 72
Dhanji, S., & Teh, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3442 · Cited by 71
“Furthermore, activated CD8 cells from DAP10-deficient mice lack NKG2D expression, suggesting that only DAP10 but not DAP12 is expressed by conventional CD8 T cells (34).”
BackgroundZloza, A., Kohlhapp, F. J., Lyons, G. E., Schenkel, J. M., Moore, T. V., Lacek, A. T., O'Sullivan, J. A., Varanasi, V., Williams, J. W., Jagoda, M. C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2683 · Cited by 66
Structural Basis for Recognition of Cellular and Viral Ligands by NK Cell Receptors
Li, Y., & Mariuzza, R. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00123 · Cited by 66
“In rodents, RAE-1, MULT-1, and H-60 are upregulated in tumor cells but not normal cells, similar to MICA and MICB in humans (137, 138).”
BackgroundNitahara, A., Shimura, H., Ito, A., Tomiyama, K., Ito, M., & Kawai, K. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700112 · Cited by 65
“…2002; Jamieson et al., 2002), the NKG2D mAb could also partially block NK cell-mediated killing of A20 cells (Figure 3c), but failed to inhibit the lysis of EL4 cells (Figure 3d) that do not express NKG2D ligands (Figure S1) (Diefenbach et al., 2000), confirming the specificity of the NKG2D mAb.”
BackgroundMethodResultInfluentialZhou, Z., Zhang, C., Zhang, J., & Tian, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036928 · Cited by 66
“The ligands for NKG2D in mice, including retinoic acid early inducible-1 (RAE-1) proteins (RAE1a, b, c, d, and e), minor histocompatibility antigen (Ag) H60 and murine UL16-binding protein-like transcript-1 (MULT-1) glycoprotein, are expressed poorly by most normal cells but upregulated in tumor cells, infected cells…”
BackgroundNatural Killer Cell Alloreactivity for Leukemia Therapy
Ruggeri, L., Mancusi, A., Perruccio, K., Burchielli, E., Martelli, M. F., & Velardi, A. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000161395.88959.1f · Cited by 71
CIK as therapeutic agents against tumors
Introna, M. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.06.008 · Cited by 66
Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature
Lowry, L. E., & Zehring, W. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01061 · Cited by 73
Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
Shin, E., Bak, S. H., Park, T., Kim, J.-W., Yoon, S. R., Jung, H., & Noh, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192907 · Cited by 79
Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.
Deng, L., & Mariuzza, R. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.004 · Cited by 67
Cappuzzello, E., Sommaggio, R., Zanovello, P., & Rosato, A. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.003 · Cited by 65
“The molecule that plays the most important role in tumor recognition by CIK cells is NKG2D, a member of the c-type lectin-activating receptor family that is normally expressed on all NK cells, and interacts with receptors almost exclusively expressed in malignant tissues [45,46].”
Raulet, D. H., Marcus, A., & Coscoy, L. (2017) · Immunological Reviews · doi:10.1111/imr.12600 · Cited by 65
Self-citationKinetics of Gene Expression in Murine Cutaneous Graft-versus-Host Disease
Sugerman, P. B., Faber, S. B., Willis, L. M., Petrović, A., Murphy, G. F., Pappo, J., Silberstein, D. S., & van den Brink, M. R. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63776-5 · Cited by 71
“GVHD is thought to be initiated by donor T cells that recognize host mHAgs, whereas NK cells could play an important role in the effector phase of the pathophysiology of cutaneous GVHD. 79 Some mHAgs bind to the activating NKG2D receptor expressed by NK cells and activated CD8 (cid:7) T cells, (cid:5)(cid:7) T cells,…”
BackgroundInfluentialFive decades of natural killer cell discovery
Lanier, L. L. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231222 · Cited by 82
“…B, and the UL16-binding protein) (Bauer et al., 1999; Kubin et al., 2001) and mice (Rae1, H60, and Mult1 proteins) (Carayannopoulos et al., 2002; Cerwenka et al., 2000; Diefenbach et al., 2000), which are induced by cellular stress, forming the basis of “ altered-self ” recognition by NK cells.”
BackgroundAn update: Epstein-Barr virus and immune evasion via microRNA regulation
Zuo, L., Yue, W., Du, S., Xin, S., Zhang, J., Liu, L.-Z., Li, G., & Lu, J. (2017) · Virologica Sinica · doi:10.1007/s12250-017-3996-5 · Cited by 70
“In virus infections and tumor proliferation, MICB expression increases, and it has been found to activate NK and T cells, thereby initiating the immune reaction (Diefenbach et al., 2000; Nachmani et al., 2009; Lisnic et al., 2010; Liu et al., 2012).”
BackgroundInnovative Clinical Perspectives for CIK Cells in Cancer Patients
Introna, M., & Correnti, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020358 · Cited by 64
“Interestingly, the ligands for NKG2D appear to have a pattern of expression that is relatively restricted to malignant tissue [21,22].”
BackgroundPD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
Jones, A. B., Rocco, A., Lamb, L. S., Friedman, G. K., & Hjelmeland, A. B. (2022) · Cancers · doi:10.3390/cancers14092339 · Cited by 72
“However, it is important to note that other cell populations critical for tumor biology also express NKG2D ligands: this pathway can influence the more differentiated, non-CSC tumor cells as well as macrophages, dendritic cells, B-cells, and T-cells [69,111,112].”
BackgroundNK Cell Development in Times of Innate Lymphoid Cell Diversity
Stokic-Trtica, V., Diefenbach, A., & Klose, C. S. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00813 · Cited by 67
Self-citationRas Activation Induces Expression of Raet1 Family NK Receptor Ligands
Liu, X. V., Ho, S. S. W., Tan, J. J., Kamran, N., & Gasser, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200965 · Cited by 60
Kelly, J. M., Takeda, K., Darcy, P. K., Yagita∥, H., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4472 · Cited by 69
Structure and Function of Natural-Killer-Cell Receptors
Sun, P. D. (2003) · Immunologic Research · doi:10.1385/ir:27:2-3:539 · Cited by 67
Recognition of infected cells by natural killer cells
Carayannopoulos, L. N., & Yokoyama, W. M. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.003 · Cited by 60
“It is expressed by all NK cells and certain subsets of T cells in both mice and humans; in mice it is also expressed by activated macrophages [17].”
BackgroundTumor-derived soluble MICs impair CD3+CD56+ NKT-like cell cytotoxicity in cancer patients
WANG, H., Yang, D., XU, W., Wang, Y., Ruan, Z., Zhao, T., Han, J., & Wu, Y. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.07.001 · Cited by 59
Catellani, S., Poggi, A. D., Bruzzone, A., Dadati, P., Ravetti, J. L., Gobbi, M., & Zocchi, M. R. (2006) · Blood · doi:10.1182/blood-2006-06-028985 · Cited by 59
NKG2D receptor–mediated NK cell function is regulated by inhibitory Ly49 receptors
Regunathan, J., Chen, Y., Wang, D., & Malarkannan, S. (2004) · Blood · doi:10.1182/blood-2004-03-1075 · Cited by 62
Strong, R. K. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00032-9 · Cited by 66
“The binding of muNKG2D to RAE-1 and H60 was characterized by relatively fast association rates compared to TCR–MHC class I interactions (O’Callaghan et al., 2001).”
BackgroundInfluentialStress, NK Receptors, and Immune Surveillance
Pardoll, D. M. (2001) · Science · doi:10.1126/science.1066284 · Cited by 65
The contribution of HLA genes to IBD susceptibility and phenotype
Yap, L. M., Ahmad, T., & Jewell, D. P. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.01.003 · Cited by 59
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D
Sayitoğlu, E. C., Georgoudaki, A., Chrobok, M., Özkazanç, D., Josey, B. J., Arif, M., Kusser, K. L., Hartman, M., Chinn, T. M., Potens, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00040 · Cited by 61
NK Cell Recognition of Mouse Cytomegalovirus-Infected Cells
Vidal, S. M., & Lanier, L. L. (2005) · Springer eBooks · doi:10.1007/3-540-27743-9_10 · Cited by 57
NK Cell Receptors as Tools in Cancer Immunotherapy
Sentman, C. L., Barber, M. A., Barber, A., & Zhang, T. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95007-6 · Cited by 61
“NKG2D ligands have been detected on carcinomas derived from colon, breast, prostate, ovary, lung, brain, liver, and kidney (Conejo‐Garcia et al., 2004; Diefenbach et al., 2000; Groh et al., 1999; Jinushi et al., 2003; Pende et al., 2002).”
InfluentialThe Ins and Outs of Body Surface Immunology
Hayday, A., & Viney, J. L. (2000) · Science · doi:10.1126/science.290.5489.97 · Cited by 57
Xiao, G., Wang, X., Sheng, J., Lu, S., Yu, X., & Wu, J. D. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0110-z · Cited by 57
“To overcome this limitation and to take the advantage that human MICB can serve as a mouse NKG2D ligand and activate mouse NKG2D [2,13-15], we have recently generated a bitransgenic TRAMP/MICB spontaneous prostate tumor”
BackgroundShoda, L., Kreuwel, H., Gadkar, K., Zheng, Y., Whiting, C., Atkinson, M., Bluestone, J., Mathis, D., Young, D., & Ramanujan, S. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04166.x · Cited by 56
Obeidy, P., & Sharland, A. F. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.07.005 · Cited by 57
“In macrophages, stimulation through NKG2D triggers TNF roduction, and the release of nitric oxide (Diefenbach et al., 2000).”
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
García-Martínez, E., Smith, M. M., Buqué, A., Aranda, F., de la Peña, F. A., Rubio, A. I., Cánovas, M. S., Conesa, M. A. V., Fucikova, J. P., Špíšek, R., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1433982 · Cited by 59
New structural insights into lectin-type proteins of the immune system
Kogelberg, H., & Feizi, T. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00259-1 · Cited by 57
Wu, J. D., Atteridge, C. L., Wang, X., Seya, T., & Plymate, S. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1305 · Cited by 58
The NKG2D-Activating Receptor Mediates Pulmonary Clearance ofPseudomonas aeruginosa
Borchers, M. T., Harris, N. L., Wesselkamper, S. C., Zhang, S., Chen, Y., Young, L., & Lau, G. W. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.2578-2586.2006 · Cited by 59
“The NKG2D receptor is expressed on circulating and tissue lymphocytes, predominantly NK cells, NK T cells, CD8 T cells, and T cells (3, 11, 23).”
BackgroundNatural killer cell‐mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions
Backström, E., Chambers, B. J., Ho, E. L., Naidenko, O. V., Mariotti, R., Fremont, D. H., Yokoyama, W. M., Kristensson, K., & Ljunggren, H. (2003) · European Journal of Immunology · doi:10.1002/immu.200390012 · Cited by 55
Hüe, S., Monteiro, R. C., Berrih-Aknin, S., & Caillat-Zucman, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1909 · Cited by 54
“These results confirm that NKG2D is not expressed on resting, but only activated T lymphocytes in mice (28), and also indicate that MIC molecules are able to bind to the murine NKG2D receptor, suggesting that NKG2D may use different epitopes to recognize its various human or mouse ligands.”
BackgroundImmune Surveillance of Unhealthy Cells by Natural Killer Cells
Iannello, A., & Raulet, D. H. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020255 · Cited by 54
“…surveillance of tumors by the demonstration that many tumors but few normal cells express NKG2D ligands (Bauer et al. 1999; Groh et al. 1999; Cerwenka et al. 2000; Diefenbach et al. 2000) and subsequently using subcutaneous tumor transfer models (Cerwenka et al. 2001; Diefenbach et al. 2001).”
Self-citationGut microbiota regulates NKG2D ligand expression on intestinal epithelial cells
Hansen, C. H. F., Holm, T. L., Krych, Ł., Andresen, L. O., Nielsen, D. S., Rune, I., Hansen, A. K., & Skov, S. (2012) · European Journal of Immunology · doi:10.1002/eji.201242462 · Cited by 61
Marcondes, A. M., Karoopongse, E., Lesnikova, M. P., Margineantu, D. H., Welte, T., Dinarello, C. A., Hockenbery, D. M., Janciauskiene, S. M., & Deeg, H. J. (2014) · Blood · doi:10.1182/blood-2014-04-570440 · Cited by 55
Li, Y., Wang, Y., Zhou, L., Liu, M., Liang, G., Yan, R., Jiang, Y., Hao, J., Zhang, X., Hu, X., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00240 · Cited by 60
Rubio, M., Saito, T. I., Kattleman, K., Zhao, G., Buchli, J., & Sykes, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.665 · Cited by 54
“The antitumor effects of RLI are not mediated by alloactivated recipient cells A20 cells are known to express Fas and retinoic acid early inducible-1, the ligand of the NK-activating receptor NKG2D (28, 29).”
BackgroundRotolo, R., Leuci, V., Donini, C., Cykowska, A., Gammaitoni, L., Medico, G., Valabrega, G., Aglietta, M., & Sangiolo, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112839 · Cited by 59
Johansson, S. (2003) · International Immunology · doi:10.1093/intimm/dxh002 · Cited by 52
Tokuyama, M., Lorin, C., Delebecque, F., Jung, H., Raulet, D. H., & Coscoy, L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002265 · Cited by 51
“Because RAE-1 molecules, along with other mouse and human NKG2D ligands, are frequently expressed on the surface of transformed cell lines as well as in some tumors in vivo [7,8], we hypothesized that RAE-1 expression in transformed cells is also dictated by p110a PI3K signaling.”
BackgroundSelf-citationPuca, E., Probst, P., Stringhini, M., Murer, P., Pellegrini, G., Cazzamalli, S., Hutmacher, C., Gouyou, B., Wulhfard, S., Matasci, M., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32603 · Cited by 51
“Stress proteins (e.g., H60a, b, c; Rae-1α-ε and Mult1) upregulated on the surface of tumor cells can be efficiently recognized by activating receptors on NK cells, such as NKG2D.58,59 Various formats of antibody-IL12 fusions have been considered over the year.28–30,60,61 The format of L19-mIL12, similar to the one pre…”
BackgroundNon‐classical major histocompatibility complex proteins as determinants of tumour immunosurveillance
Gomes, A. Q., Correia, D. V., & Silva‐Santos, B. (2007) · EMBO Reports · doi:10.1038/sj.embor.7401090 · Cited by 59
“EMBO reports VOL 8 | NO 11 | 2007 ©2007 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION1028 to enhance cytolysis and the production of IFN-γ by anti-tumour CTLs (Diefenbach et al, 2000) and γδ T lymphocytes (Girardi et al, 2001), leading to tumour rejection in vivo.”
BackgroundInfluentialThe role of natural killer cells in curbing neuroinflammation
Segal, B. M. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.006 · Cited by 50
Tkach, M., Coria, L., Rosemblit, C., Rivas, M. A., Proietti, C. J., Díaz Flaqué, M. C., Beguelin, W., Frahm, I., Charreau, E. H., Cassataro, J., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102538 · Cited by 50
“Flow cytometric analysis showed positive staining for H-60 and dim staining for RAE-1, both of which are ligands for the stimulating receptor NKG2D, in C4HD cells (Supplemental Fig.”
InfluentialNausch, N., Florin, L., Hartenstein, B., Angel, P. E., Schorpp‐Kistner, M., & Cerwenka, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.7 · Cited by 62
“It was shown that, in mice, the protein family that comprises the retinoic acid early inducible gene-1 (RAE-1 - ), H60, and MULT-1 (murine UL16-binding protein-like transcript-1) are recognized by NKG2D (3, 4).”
BackgroundImmunodeficient Mouse Strains Display Marked Variability in Growth of Human Melanoma Lung Metastases
Carreno, B. M., Garbow, J. R., Kolar, G. R., Jackson, E. N., Engelbach, J. A., Becker‐Hapak, M., Carayannopoulos, L. N., Piwnica-Worms, D. R., & Linette, G. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2502 · Cited by 53
“6A, ULBP-1, ULBP-2, and ULBP-3 expression among melanoma cell lines was heterogeneous.”
BackgroundInfluentialInhibition of MHC Class I Is a Virulence Factor in Herpes Simplex Virus Infection of Mice
Orr, M. T., Edelmann, K. H., Vieira, J., Corey, L., Raulet, D. H., & Wilson, C. B. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010007 · Cited by 55
“Phycoerythrin-conjugated tetramers were produced as previously described [37].”
MethodSelf-citationChen, R., Li, Q., Xu, S., Ye, C., Tian, T., Jiang, Q., Shan, J., & Ruan, J. (2022) · Cancer Cell International · doi:10.1186/s12935-021-02435-4 · Cited by 57
Sangiolo, D., Mesiano, G., Carnevale‐Schianca, F., Piacibello, W., Aglietta, M., & Cignetti, A. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903005552 · Cited by 49
“The most known ligands for NKG2D are relatively restricted to malignant cells and include MHC class I polypeptide-related sequence (MIC)-A, MIC-B and members of the unique long 16-binding protein (ULBP) family (ULBP1, 2 and 3) [29-31].”
BackgroundLian, R. H., Maeda, M., Lohwasser, S., Delcommenne, M., Nakano, T., Vance, R. E., Raulet, D. H., & Takei, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4980 · Cited by 48
“The detection of CD94 and NKG2D transcripts in CD34 cells in embryoid bodies and the putative common lymphoid precursor cells, respectively, suggests that the expression of these genes may be regulated differently from that of other NKG2 genes.”
BackgroundSelf-citationGeldhof, A. B., Ginderachter, J. A. V., Liu, Y., Noël, W., Raes, G., & BAETSELIER, P. D. (2002) · Blood · doi:10.1182/blood-2001-11-0106 · Cited by 55
“Indeed our analysis of the involvement of NK cells in the BW-Sp3 tumor model revealed the following main findings: (1) Progression of BW-Sp3 tumors leads to both impaired Figure 8.”
ResultDNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor
Zhou, H., Luo, Y., Lo, J., Kaplan, C. D., Mizutani, M., Mizutani, N., Lee, J.-D., Primus, F. J., Becker, J. C., Xiang, R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502208102 · Cited by 55
Granot, T., Yamanashi, Y., & Meruelo, D. (2013) · Molecular Therapy · doi:10.1038/mt.2013.215 · Cited by 53
Association of MR1 Protein, an MHC Class I-Related Molecule, with β2-Microglobulin
Yamaguchi, H., & Hashimoto, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6277 · Cited by 51
Busche, A., Goldmann, T., Naumann, U., Steinle, A., & Brandau, S. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.135 · Cited by 51
“In mice the activating stress-inducible ligands RAE-1 (retinoic acid early inducible gene product-1), minor histocompatibility antigen H60, and Mult1 have been identified (Diefenbach et al ., 2000; Carayannopoulos et al ., 2002).”
Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match
Webb, J. R., Lee, S. H., & Vidal, S. M. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363876 · Cited by 47
Rodriguez, M. R., Sabastian, P., Clark, P. Y., & Brown, M. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6312 · Cited by 47
“Their expression is mostly restricted to early development, but transformed, infected, or heat-shocked adult tissues also display these ligands (19, 20).”
BackgroundWestwood, J. A., Kelly, J. M., Tanner, J. E., Kershaw, M. H., Smyth, M. J., & Hayakawa, Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.757 · Cited by 56
“NKG2D is triggered by ligands that are structurally related to MHC class I molecules and expressed either by normal tissues early in ontogeny or by stressed, infected, and transformed tumor cells in adult life (13, 14).”
BackgroundImmunological Barriers to Embryonic Stem Cell-Derived Therapies
Šarić, T., Frenzel, L. P., & Hescheler, J. (2008) · Cells Tissues Organs · doi:10.1159/000118784 · Cited by 50
“Normally, activating NK cell ligands are predominantly expressed by virus-infected and tumor cells and are missing from normal cells, which confers selectivity of killing [Diefenbach et al., 2000; Biassoni et al., 2001].”
BackgroundFunctional Dichotomy between NKG2D and CD28-Mediated Co-Stimulation in Human CD8+ T Cells
Rajasekaran, K., Xiong, V., Lee, F., Gorski, J., & Malarkannan, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012635 · Cited by 46
“activating receptor of NK cells [2] and has been defined as a costimulatory molecule for TCR- ab and TCR-cd CD8 T cells [1].”
BackgroundVyas, Y., Maniar, H., Lyddane, C. E., Sadelain, M., & Dupont, B. (2004) · Journal of Immunology · doi:10.4049/jimmunol.173.3.1571 · Cited by 53
Adam, S. G., Caraux, A., Fodil-Cornu, N., Loredo‐Osti, J. C., Lesjean‐Pottier, S., Jaubert, J., Bubić, I., Jonjić, S., Guénet, J., Vidal, S. M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5478 · Cited by 45
“NKG2D binds at least seven different MHC class I-like cell surface glycoproteins encoded by genes clustered on mouse chromosome 10 (27, 28).”
BackgroundMethodKjellev, S. L., Haase, C., Lundsgaard, D., Ursø, B., Tornehave, D., & Markholst, H. (2007) · European Journal of Immunology · doi:10.1002/eji.200636473 · Cited by 45
Role of gammadelta T lymphocytes in tumor defense
Zocchi, M. R., & Poggi, A. D. (2004) · Frontiers in bioscience · doi:10.2741/1419 · Cited by 49
Osaki, T., Saito, H., Yoshikawa, T., Matsumoto, S., Tatebe, S., Tsujitani, S., & Ikeguchi, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1454 · Cited by 49
Du, Z., Huang, Z., Chen, X., Jiang, G., Peng, Y., Feng, W., & Huang, N. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00289-8 · Cited by 49
“As a key activating immune receptor, NKG2D is expressed on nearly all NK cells, most natural killer T (NKT) cells, γδ T cells, CD8+ T cells, and certain CD4+ T cells [30, 31].”
BackgroundRevilleza, M. J., Wang, R., Mans, J., Hong, M., Natarajan, K., & Margulies, D. H. (2011) · BioMed Research International · doi:10.1155/2011/724607 · Cited by 54
“Although such experiments support the conclusions that some of these viral MHC-I-like molecules either downregulate or impair the recognition of particular ligands, they fail to explain the precise molecular mechanism(s) involved in such regulatory effects [39, 44, 50].”
ResultBcl10 Plays a Divergent Role in NK Cell-Mediated Cytotoxicity and Cytokine Generation
Malarkannan, S., Regunathan, J., Chu, H., Kutleša, S., Chen, Y., Zeng, H., Wen, R., & Wang, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3752 · Cited by 46
Uncoupling between Immunological Synapse Formation and Functional Outcome in Human γδ T Lymphocytes
Favier, B., Espinosa, É., Tabiasco, J., Santos, C. D., Bonneville, M., Valitutti, S., & Fournié, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5027 · Cited by 47
Jachetti, E., Mazzoleni, S., Grioni, M., Ricupito, A., Brambillasca, C. S., Generoso, L., Calcinotto, A., Freschi, M., Mondino, A., Galli, R., et al. (2013) · OncoImmunology · doi:10.4161/onci.24520 · Cited by 46
Immune evasion by TGFβ-induced miR-183 repression of MICA/B expression in human lung tumor cells
Trinh, T. L., Kandell, W. M., Donatelli, S. S., Tu, N., Tejera, M. M., Gilvary, D. L., Eksioglu, E. A., Burnette, A., Adams, W. A., Liu, J., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2018.1557372 · Cited by 42
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
Ruggeri, L., Mancusi, A., Burchielli, E., Perruccio, K., Aversa, F., Martelli, M., & Velardi, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.007 · Cited by 49
Chen, J., Guo, W., Du, P., Cui, T., Yang, Y., Wang, Y., Kang, P., Zhang, Z., Wang, Q., Ye, Z., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6073 · Cited by 56
Markiewicz, M. A., Wise, E. L., Buchwald, Z. S., Pinto, A. K., Zafirova, B., Polić, B., & Shaw, A. S. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.014 · Cited by 47
“Most studies suggest that NKG2D can act as a costimulatory receptor for cytotoxic T lymphocytes (CTLs), enhancing T cell receptor (TCR)-driven responses (Bauer et al., 1999; Chalupny et al., 2003; Cosman et al., 2001; Diefenbach et al., 2000; Markiewicz et al., 2005; Sutherland et al., 2002).”
BackgroundDhanji, S., Teh, S.-J., Oble, D. A., Priatel, J. J., & Teh, H. (2004) · Blood · doi:10.1182/blood-2004-01-0150 · Cited by 44
Franzese, O., & Graziani, G. (2022) · Cancers · doi:10.3390/cancers14225633 · Cited by 55
Klezovich-Bénard, M., Corre, J.-P., Jusforgues-Saklani, H., Fiole, D., Burjek, N., Tournier, J., & Goossens, P. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002481 · Cited by 41
“The activating receptor, NKG2D, elicits cytokine production by NK cells [31,32].”
BackgroundClinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma
Zhang, Y., Ellinger, J., Ritter, M., & Schmidt‐Wolf, I. G. H. (2020) · Cancers · doi:10.3390/cancers12092471 · Cited by 41
“NKG2D, a member of the c-type lectin-activating receptor family, recognizes the MHC-class I-like molecules, MICA and MICB and members of the ULBP family (ULPB1-4) that are restrictedly expressed on malignant tissues and mediates subsequently granzyme release [14].”
BackgroundMurine NKG2D ligands: “Double, double toil and trouble”
Samarakoon, A., Chu, H., & Malarkannan, S. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.035 · Cited by 44
“However, past studies including from our laboratory have exclusively used model tumor cells that have been stably transfected to express the NKG2D ligands(Diefenbach et al., 2000;Cerwenka et al., 2000;Regunathan et al., 2005).”
Background
Metadata
- Authors
- Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature Immunology
- Published
- 2000-08
- Volume
- 1
- Issue
- 2
- Pages
- 119-126
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1603913234
- Cited by
- 878
- References
- 41
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 17 · 2023: 12 · 2022: 28 · 2021: 17 · 2020: 23 · 2019: 18 · 2018: 29 · 2017: 31 · 2016: 17 · 2015: 23 · 2014: 24 · 2013: 28 · 2012: 38
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NKG2D, NKG2D ligands, natural killer cells, macrophages, cancer cells, innate immunity, NK cell cytotoxicity, interferon-gamma, nitric oxide, TNF-α, MHC class I-related molecules, CD8+ T cells, expression cloning
- MeSH terms
- Animals, Chlorocebus aethiops, Cloning, Molecular, Cricetinae, Humans, Killer Cells, Natural, Ligands, Lymphocyte Activation, Macrophage Activation, Membrane Proteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, Immunologic, Tumor Cells, Cultured, Minor Histocompatibility Antigens, CHO Cells, Macrophages, Peritoneal, COS Cells, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.